MME Calculator
Convert opioid doses to morphine milligram equivalents (MME) for risk assessment. Enter medications, doses, and frequency to calculate total daily MME and understand risk thresholds.
Medical Disclaimer
This calculator is for educational purposes only. It does not provide medical advice and should not be used for prescribing decisions. Always consult a qualified healthcare provider.
Calculate MME
Results
Editorial & Review Information
Reviewed on: 2026-02-24
Author: LumoCalculator Editorial Team
Editorial review: Medical content reviewed against CDC opioid guidance and public conversion references.
Purpose and scope: This tool is for educational risk screening and care planning context only. It is not intended for prescribing, dose conversion between opioids, or individual medical decision-making.
Use Scenarios
Scenario A: Multi-opioid regimen review
Estimate combined daily opioid burden when a patient takes more than one opioid product.
Scenario B: Threshold risk screening
Compare current therapy with commonly used caution ranges (for example around 50 and 90 MME/day) as part of risk context.
Scenario C: Follow-up trend tracking
Track whether total daily opioid exposure is trending up or down across follow-up visits.
What Is Morphine Milligram Equivalent (MME)?
Morphine Milligram Equivalent (MME) is a standardized way to express opioid dosage across different medications. Because opioids vary in potency—oxycodone is roughly 1.5× stronger than morphine, hydromorphone is 4× stronger—comparing raw doses is misleading. MME converts everything to a morphine-equivalent scale, allowing meaningful comparison of total opioid burden.
The concept emerged from the opioid crisis as a tool for risk assessment. Research showed that overdose risk increases sharply above certain daily MME thresholds, regardless of which specific opioid a patient takes. The CDC 2022 guideline continues to use MME as risk context, where common thresholds are caution points rather than fixed treatment rules, and many prescription monitoring programs (PDMPs) now track MME as a key risk indicator.
The Basic Formula
For example: 30 mg oxycodone/day × 1.5 = 45 MME/day. A patient taking this amount has an opioid burden equivalent to 45 mg of oral morphine daily.
MME is not meant to guide dose conversions when switching between opioids—that requires different calculations with safety margins for incomplete cross-tolerance. MME is specifically designed for cumulative risk assessment: when a patient takes multiple opioids or when comparing prescribing patterns across populations.
Formula & Standard Sources
- MME formula basis: Daily dose multiplied by opioid-specific conversion factor as documented in CDC and CMS conversion references.
- Risk threshold basis: Common caution thresholds (such as around 50 and 90 MME/day) are referenced in CDC opioid guidance and related epidemiologic risk analyses for context, not as automatic stop rules.
- Special conversion handling: Methadone uses dose-dependent factors and fentanyl patches use a route-specific conversion approach.
MME Conversion Factors by Drug
Each opioid has a specific conversion factor based on its potency relative to oral morphine. These factors come from pharmacological research and clinical consensus, though there is some variation between different published conversion tables.
| Opioid | Conversion Factor | Example: 30mg/day | Notes |
|---|---|---|---|
| Morphine (oral) | 1.0 | 30 MME | Reference standard |
| Oxycodone | 1.5 | 45 MME | Common Rx opioid |
| Hydrocodone | 1.0 | 30 MME | Similar to morphine |
| Hydromorphone | 4.0 | 120 MME | High potency |
| Codeine | 0.15 | 4.5 MME | Low potency |
| Tramadol | 0.1 | 3 MME | Weak opioid |
| Tapentadol | 0.4 | 12 MME | Dual mechanism |
| Methadone | 4-15* | Variable | Dose-dependent! |
| Fentanyl Patch | 2.4/mcg/hr | N/A | Special calculation |
⚠️ Special Cases: Methadone and Fentanyl
Methadone has a non-linear conversion—the factor increases with higher doses because of its unique pharmacokinetics and long half-life:
- • 1-20 mg/day: factor = 4
- • 21-40 mg/day: factor = 8
- • 41-60 mg/day: factor = 10
- • 61-80 mg/day: factor = 12
- • >80 mg/day: factor = 15
Fentanyl patches use a different formula: MME = mcg/hr × 2.4. A 25 mcg/hr patch = 60 MME/day. This accounts for continuous 72-hour transdermal delivery.
These factors are for oral administration unless otherwise noted. IV, IM, or other routes have different bioavailability and may require adjusted calculations.
MME Risk Thresholds: What the Numbers Mean
The CDC's 2022 guidance continues to use MME as a population-level risk context signal. Higher daily dose ranges are associated with higher observed overdose risk, but these ranges are caution points rather than rigid cutoff rules. Clinical context and individualized judgment remain essential.
Most patients at this level can be managed with routine follow-up. Overdose risk exists but is relatively low. Standard precautions apply: avoid combining with benzodiazepines, assess for sleep apnea, monitor for signs of misuse.
Research shows overdose risk increases substantially above 50 MME/day. CDC recommends careful justification, enhanced monitoring (urine drug screens, PDMP checks), and discussing naloxone with patients. Consider specialist consultation for chronic use.
Observational studies show substantially increased overdose risk at this level. Use closer monitoring, naloxone discussion, and clear documentation of clinical rationale when therapy is continued. Some jurisdictions or payer policies may impose additional requirements; always follow current local laws, institutional policy, and specialist input when appropriate.
Important context: These thresholds were developed primarily for chronic non-cancer pain. Cancer pain, palliative care, and opioid use disorder treatment may appropriately exceed these levels. The thresholds identify statistical risk—individual patients with tolerance may be at lower risk at higher doses, while opioid-naive patients may be at significant risk even below 50 MME.
Clinical Scenarios: Calculating MME in Practice
Scenario 1: Post-Surgical Patient on Multiple Opioids
Calculating cumulative MME from combination therapy
A patient recovering from knee replacement is taking Oxycodone 10mg every 6 hours (4×/day) plus Morphine IR 15mg at bedtime for breakthrough pain.
MME Calculation:
Clinical Implications:
At 75 MME/day, this patient is in the "increased risk" category. For short-term post-operative use (days to 1-2 weeks), this may be appropriate with close monitoring. The prescriber should have a taper plan, avoid concurrent benzodiazepines, and consider naloxone education. Transition to non-opioid alternatives should begin as healing progresses.
Scenario 2: Chronic Pain Patient with Fentanyl Patch
Understanding high-MME therapy in established patients
A patient with chronic back pain has been stable on Fentanyl 50 mcg/hr patch (changed every 72 hours) plus Hydromorphone 4mg twice daily for breakthrough pain.
MME Calculation:
Clinical Implications:
At 152 MME/day, this patient is well above the high-risk threshold. However, for an established chronic pain patient with documented tolerance, sudden dose reduction would be inappropriate and potentially harmful. Management should involve: confirming medical necessity, pain specialist oversight, regular PDMP checks, naloxone prescription, and exploring multimodal alternatives. Any tapering should be gradual (10% reduction per month maximum).
Scenario 3: Opioid-Naive Patient After ED Discharge
Using MME as a short-course risk check before discharge counseling
A patient with an acute fracture is discharged with Hydrocodone 5mg every 6 hours as needed, up to 4 doses per day, for 3 days.
MME Calculation:
Clinical Implications:
Although this total is below common caution thresholds, opioid-naive patients can still have sedation and respiratory risk. Counsel on shortest effective duration, avoiding alcohol or sedatives, and returning for reassessment if pain is uncontrolled.
Important Limitations of MME Calculations
MME is a useful screening tool, but it has significant limitations that users must understand to avoid misapplication.
🧬 Individual Variation
Opioid metabolism varies by genetics (CYP2D6 polymorphisms), age, liver function, and kidney function. The same MME can produce vastly different effects in different patients.
⏱️ Tolerance Effects
Patients on chronic opioid therapy develop tolerance. A patient stable on 100 MME/day for years has a different risk profile than an opioid-naive patient receiving the same dose.
💊 Route Matters
These factors assume oral dosing. IV administration has higher bioavailability. Transdermal, buccal, and intranasal routes each have different absorption profiles.
⚠️ Not for Dose Conversion
MME tables should NOT be used to convert between opioids when changing medications. Equianalgesic dose conversion requires different calculations with safety reductions.
🚫 What MME Cannot Tell You
- • Whether a specific patient will overdose
- • The appropriate dose for any individual
- • Whether current therapy is effective for pain control
- • How to safely taper or convert medications
- • Risk from concurrent substance use (benzodiazepines, alcohol)
Frequently Asked Questions
What is MME and why does it matter?
MME (Morphine Milligram Equivalent) standardizes opioid potency for comparison. CDC guidance commonly references around 50 and 90 MME/day as caution points in population-level risk analyses, not absolute rules for every patient. It helps clinicians assess cumulative opioid burden.
How accurate are MME conversions?
MME conversions are approximations, not exact equivalencies. Individual factors (tolerance, metabolism, route) affect actual potency. Methadone and fentanyl conversions are particularly variable. Use for risk screening, not dose titration.
Why is methadone conversion different?
Methadone has a long, variable half-life and non-linear dose-response. Higher doses have disproportionately greater MME values (e.g., 20mg = 4×, 60mg = 10×). This makes methadone conversion especially complex and dangerous to estimate.
Can I use this to adjust prescriptions?
No. This calculator is for educational risk assessment only. Opioid prescribing decisions require clinical evaluation, patient history, and professional judgment. Never change medications based solely on MME calculations.
📚 Sources & References
- CDC Clinical Practice Guideline for Prescribing Opioids (2022) - Current CDC recommendations
- CDC Overdose Prevention Clinical Guidance - Clinical risk framework and opioid prescribing context
- NCBI Bookshelf: Opioid Equivalency - Background reference for opioid dose equivalence concepts and limitations